2022 annual meeting

AntibodyPlus: next generation antibody-based biologics

Oct. 30, 2022, 8:30 a.m. US/Eastern

in person, Cambridge MA

Login to view recordings

Overview

In the midst of the rapid development of novel antibody therapies and the “new normal” of the pandemic, the Chinese Antibody Society (CAS) will hold the 2022 Annual Conference in Boston on October 30, 2022 (Sunday). This will be the first in-person event of the Chinese Antibody Society since the pandemic started. The topic of the CAS 2022 Annual Conference is: “AntibodyPlus: next generation antibody-based biologics.” The Chinese Antibody Society will continue to provide a platform for accelerating antibody-based therapies research and development, and will strive to make an active contribution to the global therapeutic antibody research and development community.

AntibodyPlus™ is a new concept developed by the Chinese Antibody Society to cover various antibody-derived therapeutic compounds and drugs, e.g., direct fusion/coupling of therapeutic agents to antibodies, gene therapies that express antibodies through mRNA, DNA plasmids, etc. The evolution from the monoclonal antibody to AntibodyPlus™ reflects the rapid development and innovation in the therapeutic antibody field. The CAS 2022 Annual Conference will primarily focus on the research frontier of antibody therapies, the latest development of technologies in this field, and the opportunities in the global antibody research field.

Conference Registration for CAS members (Not a member yet? Register to become a Chinese Antibody Society member on our website: https://chineseantibody.org/member-signup/)

Early bird registration is available before September 30, 2022:
Conference registration fee ($15); Dinner registration fee ($100).

Registration on or after October 1, 2022:
Conference registration fee ($30); Dinner registration fee ($150).

Conference Registration for non-members

Early bird registration is available before September 30, 2022:
Conference registration fee ($30); Dinner registration fee ($100).

Registration on or after October 1, 2022:
Conference registration fee ($50); Dinner registration fee ($150).

Please register at your earliest convenience. Once the maximum number of registered participants is reached, the registration portal will be closed automatically. But you may be able to register on site on October 30, 2022.

HOST HOTEL:
Boston Marriott Cambridge
50 Broadway, Cambridge, MA 02142

Download conference brochure

Sponsors

Dinner

Premium

Speakers

Hover above speaker cards to read bio

bio

Judy Lieberman MD PhD

Endowed Chair, Harvard Medical School

bio

Mitchell Ho, Ph.D.

Senior Investigator, NIH

bio

Paul Parren

EVP and Head of R&D, Lava Therapeutics

bio

Jingsong Wang, Ph.D.

CEO, Harbour BioMed

bio

Shirley Liu, PhD

CEO, GV20

bio

Zhiqiang An

Professor of Molecular Medicine, University of Texas Health Science Center at Houston

bio

Kenneth LaMontagne

SVP, IN8bio

bio

John Lambert

Consultant/Scientific Advisor, Queen’s University Belfast

bio

Chen Ni Chin

Senior Director, IGM Biosciences

bio

Yue Liu, PhD, MBA

Associate Director, Generate Biomedicines

bio

Hao Cheng, PhD

CSO, Yurogen

bio

Shouye Wang, Ph.D.

Board Director, Chinese Antibody Society

bio

Zhidan Tu, Ph.D.

Presedent, Chinese Antibody Society

bio

Bo Liu, Ph.D

President-elect, Chinese Antibody Society

bio

Zhinan Xia, Ph.D

CSO, DynamiCure Biotechnology

Agenda

Starts at 10/30/2022 8:30 a.m. US/Eastern

Hover to view abstract

10/30/2022 7:30 a.m. US/Eastern

Registration and Breakfast

Organizer, TBD, The Chinese Antibody Society

10/30/2022 8:30 a.m. US/Eastern

Openning remarks

Shouye Wang, Ph.D., Board Director, Chinese Antibody Society

10/30/2022 8:40 a.m. US/Eastern

Announcements of Chinese Antibody Society

Zhidan Tu, Ph.D., Presedent, Chinese Antibody Society

10/30/2022 8:45 a.m. US/Eastern

Yearly Review of Chinese Antibody Society

Bo Liu, Ph.D, President-elect, Chinese Antibody Society

10/30/2022 8:50 a.m. US/Eastern

Morning session Moderator

Zhinan Xia, Ph.D, CSO, DynamiCure Biotechnology

10/30/2022 8:55 a.m. US/Eastern

Antibody mediated SARS CoV2 Infection of Monocytes and Macrophages Activates Inflammation

Judy Lieberman MD PhD, Endowed Chair, Harvard Medical School

10/30/2022 9:25 a.m. US/Eastern

Advances in Solid Tumor CART Cell Therapy

Mitchell Ho, Ph.D., Senior Investigator, NIH

10/30/2022 9:55 a.m. US/Eastern

Coffee break

Organizer, TBD, The Chinese Antibody Society

10/30/2022 10:35 a.m. US/Eastern

Building Next Gen Biologics Leveraging Industry Leading Technology Platforms

Jingsong Wang, Ph.D., CEO, Harbour BioMed

10/30/2022 11:05 a.m. US/Eastern

Integrated Genomics and AI Approach for IO Target and Drug Discovery

Shirley Liu, PhD, CEO, GV20

10/30/2022 11:35 a.m. US/Eastern

Combining gamma delta T cells with Bispecific Antibodies to fight cancer

Kenneth LaMontagne, SVP, IN8bio

10/30/2022 12:05 p.m. US/Eastern

Lunch

Organizer, TBD, The Chinese Antibody Society

10/30/2022 1:25 p.m. US/Eastern

Afternoon session Moderator

Mitchell Ho, Ph.D., Senior Investigator, NIH

10/30/2022 1:30 p.m. US/Eastern

Academic drug discovery challenges and opportunities

Zhiqiang An, Professor of Molecular Medicine, University of Texas Health Science Center at Houston

10/30/2022 2 p.m. US/Eastern

Bispecific and avidity engineered antibodies in biotherapeutic drug design

Paul Parren, EVP and Head of R&D, Lava Therapeutics

10/30/2022 2:30 p.m. US/Eastern

Machine learning guided generation of antibody therapeutics

Yue Liu, PhD, MBA, Associate Director, Generate Biomedicines

10/30/2022 3 p.m. US/Eastern

Coffee break

Organizer, TBD, The Chinese Antibody Society

10/30/2022 4 p.m. US/Eastern

A Novel Single B cell Based Platform for Monoclonal Antibody Discovery

Hao Cheng, PhD, CSO, Yurogen

10/30/2022 4:30 p.m. US/Eastern

Engineered IgM antibodies as potential therapeutics

Chen Ni Chin, Senior Director, IGM Biosciences

10/30/2022 5 p.m. US/Eastern

ANTIBODY DRUG CONJUGATES Decades of Study Successful Product Developments and a Resurgence of Interest

John Lambert, Consultant/Scientific Advisor, Queen’s University Belfast

10/30/2022 5:30 p.m. US/Eastern

Exhibit

Organizer, TBD, The Chinese Antibody Society

10/30/2022 6:30 p.m. US/Eastern

Dinner

Organizer, TBD, The Chinese Antibody Society

FAQ of Meeting Registration

If you have any questions, feel free to reach out to us
Icon